Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 796-a-797-a, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woitas, R. P.
Right arrow Articles by Joven, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Woitas, R. P.
Right arrow Articles by Joven, J.
Related Collections
Right arrow Nutrition
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:796-797.)
© 2002 American Association for Clinical Chemistry, Inc.

Letters

Increased Homocysteine in Liver Cirrhosis: A Result of Renal Impairment?

Rainer P. Woitas1a, Birgit Stoffel-Wagner2, Uwe Poege1 and Tilman Sauerbruch1

1 Medizinische Klinik und Poliklinik I Allgemeine Innere Medizin and
2 Department of Clinical Biochemistry University of Bonn D-53105 Bonn, Germany

aAddress correspondence to this author at: Medizinische Klinik und Poliklinik I, Allgemeine Innere Medizin, Universitaet Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany. Fax 49-228-287-4323; e-mail Woitas@uni-bonn.de.


To the Editor:

In their recent publication, Ferré et al. (1) investigated homocysteine concentrations in 76 patients with liver cirrhosis. The majority of these patients suffered from alcoholic liver disease (63%). The authors described significantly increased homocysteine in nonabstaining alcoholic patients with cirrhosis. Furthermore, the homocysteine concentrations were inversely correlated with the severity of the liver disease (Child–Pugh score) and with the folate concentrations in these patients. The authors proposed that the homocysteine concentration was influenced by alcohol intake and by the degree of liver impairment. The authors conclude that nonnutritional factors may affect homocysteine concentrations.

Hyperhomocysteinemia also occurs in patients with decreased renal function, but the investigators provided no information about the renal function of these patients. Renal function is considerably reduced in patients with compensated cirrhosis (2). An inverse relationship between the glomerular filtration rate (GFR) and plasma homocysteine has been noted, and declining renal function is associated with higher plasma homocysteine concentrations (3).

We studied 23 patients with liver cirrhosis (median age, 54 years; range, 20–68 . . . [Full Text of this Article]


Acknowledgments


References

Natàlia Ferré, Jordi Campsb and Jorge Joven

Centre de Recerca Biomèdica Institut de Recerca en Ciències de la Salut Hospital Universitari de Sant Joan C/. Sant Joan s/n 43201-Reus, Catalunya, Spain

bAddress correspondence to this author at: Centre de Recerca Biomèdica, Hospital Universitari de Sant Joan, C/. Sant Joan s/n, 43201-Reus, Catalunya, Spain. Fax 34-977-312569; e-mail jcamps@grupsgs.com.


To the Editor:


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.